Tate & Lyle’s price target has seen a modest revision, with its fair value estimate trimmed from £5.28 to £5.14 per share. This shift comes as analysts balance cautious optimism with new concerns, taking into account a higher discount rate and notably slower projected revenue growth. Stay tuned to find out how investors and followers can keep track of these evolving expectations in the coming months.

Stay updated as the Fair Value for Tate & Lyle shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Tate & Lyle.

Recent analyst commentary provides insight into the evolving consensus on Tate & Lyle, with a mix of caution and select optimism reflected in both recent rating changes and price target adjustments.

???? Bullish Takeaways

Citi maintains a Buy rating despite lowering their price target to 540 GBp from 670 GBp. This signals ongoing confidence in Tate & Lyle's underlying business.

Bullish analysts reward the company for its execution and transparency but remain alert to the impact of slower growth and potential near-term volatility.

Even among neutral or cautious commentary, price targets remain at a premium to current trading levels. This highlights belief in the company’s long-term resilience.

???? Bearish Takeaways

Barclays’ Alex Sloane downgraded Tate & Lyle to Equal Weight from Overweight and reduced the price target to 430 GBp from 650 GBp. Sloane points to concerns that revised fiscal guidance may still be too optimistic and could be tested by an upcoming contract renewal round.

Morgan Stanley’s Lisa De Neve has downgraded the stock to Underweight from Equal Weight and lowered their price target to 500 GBp from 590 GBp. She cites increased risk to medium-term targets after Tyson Foods' move away from sucralose in U.S. products.

Earlier, Morgan Stanley initiated coverage with an Equal Weight stance and underlined that near-term growth could be “clouded” by a softer and deflationary market environment.

Concerns among bearish analysts focus on the sustainability of recent performance, the robustness of new management guidance, and competitive pressures in key markets.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

The Board has approved an interim dividend of 6.6 pence per share, an increase from last year's 6.4 pence. This dividend will be paid on 5 January 2026 to shareholders on record as of 21 November 2025.

Tate & Lyle has reaffirmed its earnings guidance for the full year ending 31 March 2026. The company expects overall revenue to decline by a low single-digit percentage compared to the previous year.

For the first half of the fiscal year, the company anticipates a 3% to 4% decline in revenue on a constant currency, pro forma basis when compared to the same period last year.

Fair Value: Decreased slightly from £5.28 to £5.14 per share.

Discount Rate: Increased modestly from 6.82% to 7.07%.

Revenue Growth: Declined significantly from 7.29% to 3.38%.

Net Profit Margin: Improved marginally from 9.18% to 9.35%.

Future P/E: Decreased from 17.71x to 16.66x.

Narratives are a smarter way to invest, combining real investor perspectives with financial forecasts to tell the full story behind a company's numbers. On Simply Wall St, millions of users build and follow Narratives available on each company's Community page. These Narratives link strategy to expected cash flows and Fair Value. Narratives help you decide when to buy or sell by comparing Fair Value to the current Price, and they update dynamically as new news or earnings are reported.

Discover the full story and unique insights shaping Tate & Lyle’s investment outlook by reading the original Narrative here and stay ahead on:

Tate & Lyle’s expansion through CP Kelco, aiming to boost revenue growth and profitability via cost synergies and a stronger specialty portfolio.

How cash flows, disciplined buybacks, and groundbreaking product innovation are set to drive future earnings and shareholder returns.

The biggest risks ahead, from input cost deflation and revenue declines in Europe to execution challenges in the latest major acquisition.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include TATE.L.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com